SYDNEY — The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic. we had with Delta,” Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview. Bancel added that the high number of mutations on the protein spike the virus uses to infect human cells meant it was likely the current crop of vaccines would need to be modified. He had earlier said on CNBC that it could take months to begin shipping a vaccine that does work against Omicron. I agree to the Terms of Use and acknowledge that I have read the Privacy PolicyRead Next

Source: Philippine Daily Inquirer November 30, 2021 09:12 UTC